Investor insights
Sectors invested in
Funding rounds participated in
$82M sweet spot round size
Most of their 11 investments are in rounds between $40M and $125M
Investor type
Basic info
Industry
Sectors
Date founded
2010
Investments made
Undisclosed raised $290M on April 19, 2023
Investors: 华盖资本有限责任公司, CITIC Private Equity Funds Management and GL Capital Group
Undisclosed raised undisclosed on November 16, 2022
Investors: IDG Capital Partners and GL Capital Group
Wuxi NEST Biotechnology Co.,Ltd raised undisclosed on June 7, 2022
Investors: Legend Capital, China Pacific Insurance Company and GL Capital Group
ImmunOs Therapeutics AG raised $73M on June 7, 2022
Investors: Gimv, PEAK6, Samsara BioCapital, Mission BioCapital, Redalpine, Lightspeed Venture Partners and GL Capital Group
Duoning raised undisclosed on November 24, 2021
Investors: Sequoia Capital China, Lake Bleu Capital (Hong Kong) Limited and GL Capital Group
Hzymes Prk Biotech raised $125M on November 10, 2021
Investors: Industrial Bank Co., Ltd. and GL Capital Group
Undisclosed raised $78M on June 15, 2021
Investors: 博华资本, Oceanpine Capital, Everest Venture Capital and GL Capital Group
NewAmsterdam Pharma raised $194M on January 14, 2021
Investors: Forbion, Morningside Venture Capital 晨兴资本, JVC Investment Partners, Medpace, Presight Capital, LSP (Life Sciences Partners) and GL Capital Group
广州华银医学检验中心有限公司 raised $85M on April 8, 2020
Investors: 深圳蓝海创业投资基金管理有限公司, Everest Venture Capital, QianHai FoFs and GL Capital Group
Oxford BioDynamics Plc raised $13M on August 24, 2018
Investors: GL Capital Group